Release Date: 03/09/12 16:14 Summary: TriAusMin Letter to Option Holders Price Sensitive: No Download Document 65.22KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%